Palisade Capital Management LP Makes New Investment in Acadia Healthcare Company, Inc. $ACHC

Palisade Capital Management LP purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 456,960 shares of the company’s stock, valued at approximately $13,494,000.

Other hedge funds have also recently made changes to their positions in the company. EverSource Wealth Advisors LLC raised its position in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares in the last quarter. Federated Hermes Inc. grew its position in Acadia Healthcare by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after buying an additional 668 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in Acadia Healthcare by 0.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock worth $1,063,000 after buying an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio increased its stake in Acadia Healthcare by 2.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock worth $776,000 after acquiring an additional 867 shares during the last quarter. Finally, Treasurer of the State of North Carolina raised its holdings in shares of Acadia Healthcare by 2.1% in the 2nd quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after acquiring an additional 867 shares in the last quarter.

Acadia Healthcare Stock Up 4.0%

Shares of Acadia Healthcare stock opened at $29.87 on Wednesday. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The company’s fifty day simple moving average is $30.14 and its two-hundred day simple moving average is $25.81. The company has a market cap of $2.78 billion, a P/E ratio of -2.40, a PEG ratio of 9.25 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 12-month low of $11.43 and a 12-month high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.35 by $0.03. The firm had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company’s quarterly revenue was down .4% compared to the same quarter last year. During the same period last year, the company posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Analyst Ratings Changes

Several brokerages have recently commented on ACHC. Guggenheim boosted their price objective on Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. Royal Bank Of Canada raised their target price on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. UBS Group boosted their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Finally, KeyCorp lifted their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Acadia Healthcare currently has an average rating of “Hold” and a consensus target price of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.